期刊文献+

肺抑瘤合剂对A549裸鼠移植瘤生长抑制的实验研究 被引量:3

Experimental Study of Feiyiliu Mixture on Inhibiting the Growth of Lung Cancer A549 Xenograft Tumor in Nude Mice
下载PDF
导出
摘要 目的:探讨肺抑瘤合剂对肺癌A549细胞系裸鼠皮下移植瘤生长的抑制作用并探讨其机制。方法:建立肺癌A549细胞系裸鼠移植瘤动物模型,随机分为对照组、肺抑瘤合剂组及顺铂组灌胃或腹腔注射给药干预,观察肺抑瘤合剂对裸鼠移植瘤生长的影响;采用Real-Time PCR方法检测表皮生长因子受体(EGFR)表达,Western-Blot方法检测EGFR、P38、GSK3β和AKT表达。结果:肺抑瘤合剂有较为明显的抑瘤效果(P<0.05)。与对照组相比,肺抑瘤合剂组和顺铂组移植瘤组织中EGFR m RNA表达水平明显下调(P<0.05)。EGFR及p-EGFR蛋白水平有下降趋势,但无统计学意义。P38、GSK3β及AKT蛋白表达无明显变化,而p-P38、p-GSK3β及p-AKT的水平明显下调(P<0.05)。结论:肺抑瘤合剂对肺癌A549裸鼠移植瘤有明显抑制作用,可能通过抑制P38、GSK3β和AKT蛋白的磷酸化水平,起到抑制移植瘤生长的效果。 Objectives:To observe the effect of Feiyiliu mixture on inhibiting lung cancer A549 xenograft tu- mor innude mice and to investigate the underlying mechanisms. Method:Nude micewere transplanted with lung cancer A549 cell line,and weredivided into the control group,Feiyiliu mixture group,and cisplatin group. The effect of Feiyiliu mixture on inhibiting the growth of xenograft tumor was observed. Epidermal growth factor receptor(EGFR) mRNA ]evelwas detected by real-time PCR,andEGFR,P38,GSK313 and AKT levels were detected withwestern blot assay. Results:Feiyiliu mixture had significant effects of inhibiting tu mot growth(P〈O.05).Compared with the control group,EGFR mRNA level in the tumor tissues in both the Feiyiliu mixture group and cisplatin group was down-regulated(P〈0.OS),and the protein level of EGFR and p-EGFR also showed a trend of decreasing,but without statistical significance;protein level of P38,GSK313 and AKT showed no significant changes,but the protein levels of p-P38,p-GSK3131 and p-AKTwere signifi- candy down-regulated(P〈0.05). Conclusion:Feiyiliu mixture couldinhibit the growth of lung cancer A549 xenograft tumor in nude mice,possibly through inhibiting phosphorylation levels of protein P38,GSK313 and AKT to restrain tumor growth,
出处 《山东中医杂志》 2016年第10期901-904,共4页 Shandong Journal of Traditional Chinese Medicine
关键词 肺抑瘤合剂 A549 肺肿瘤 顺铂 移植瘤 抑制 Feiyiliu mixture A549 lung cancer cisplatin xenograft tumor inhibition
  • 相关文献

参考文献12

  • 1Torre L A,Bray F,Siegel R L,et al. Global cancer statistics, 2012 [J~. CA :A Cancer Journal for Clinicians,2015,65 (2) : 87- 108.
  • 2陈万青,张思维,邹小农.中国肺癌发病死亡的估计和流行趋势研究[J].中国肺癌杂志,2010,13(5):488-493. 被引量:516
  • 3李家望,郑心,李士涛.肺抑瘤合剂联合厄洛替尼治疗肺腺癌的临床研究[J].中外健康文摘,2011,41(8):187-188.
  • 4刘显涛.肺抑瘤合剂治疗原发性支气管肺癌的临床研究[J].山东中医药大学学报,2004,28(2):99-102. 被引量:2
  • 5姚晓军,刘伦旭.肺癌的流行病学及治疗现状[J].现代肿瘤医学,2014,22(8):1982-1986. 被引量:427
  • 6Amendt C,Staub E ,Friese-Hamim M ,et al. Association of egfr expression level and cetuximab activity in patient-derived xeno- graft models of human non-small cell lung cancer[J]. Clinic',d cancer research:an official journal of the Aanerican Association for Cancer Research ,2014,20( 17 ) :4478-4487.
  • 7Schuette W ,Sehirmacher P,Eberhardt W E,et al. Egfr mutation status and first-line treatment in patients with stage iii/iv non- small cell lung cancer in germany:An observational study[J]. Cancer epidemiology, biornarkers & prevention : a publication of the American Association for Cancer Research ,cosponsored by the American Society of Preventive Oncology,2015,24(8) : 1254- 1261.
  • 8Taylor C A,Zheng Q,Liu Z,et al. Role of p38 and jnk mapk signaling pathways and ttonor suppressor p53 on induction of apoptosis in response to ad-eif5al in a549 lung cancer cells[J]. Molecular cancer,2013(12) :35.
  • 9Aldonza M B,Hong J Y,Bae S Y,et al. Suppression of mapk signaling and reversal of mtor-dependent mdrl-associated mul- tidrug resistance by 21alpha-methylmelianodiol in lung cancer cells[J]. PluS one,2015,10(6) :e0127841.
  • 10Perez-Ramirez C ,Canadas-Garre M ,Molina M A ,et al. Pten and pi3k/akt in non-small-cell lung cancer[J]. :Pharmacogeno- mics, 2015,16(16) : 1843-1862.

二级参考文献37

共引文献932

同被引文献96

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部